News & Events
National Academy of Inventors Honors Two Jefferson Researchers with Highest Professional Distinction for Academic Inventors
The National Academy of Inventors (NAI) selection committee elected D. Craig Hooper, PhD, and Mathew Thakur, PhD, of Thomas Jefferson University to Fellow status, indicating a prolific spirit of innovation in creating or facilitating inventions that have made a tangible impact on quality of life, economic development and the welfare of society.
Jefferson Receives $2.5 Million from the Robert V. Nicoletti Family Trust for New Kidney Transplant Center
Jefferson Health announced a $2.5 million gift from the Robert V. Nicoletti Family Trust to establish a new kidney transplant center with a special focus on living donor transplantation. The Nicoletti Kidney Transplant Center at Jefferson brings together research, education and clinical care in one space.
Jefferson Receives $3 Million from Australian Philanthropist to Support Research in Medicinal Cannabis and Hemp
The Institute of Emerging Health Professions at Thomas Jefferson University has received a $3 million gift from Australian philanthropists, Barry and Joy Lambert, to support its Center for Medical Cannabis Education and Research.
Christine Ann Arenson, MD, Named Alumni Professor and Chair of Family and Community Medicine at Jefferson
The Sidney Kimmel Medical College at Thomas Jefferson University named Christine Anne Arenson, MD, the Alumni Professor and Chair of the Department of Family and Community Medicine. In this role, Dr. Arenson will oversee more than 50 employed faculty members and guide the department’s research, education and clinical goals.
Jefferson Selected for National Pilot Program Aimed at Maximizing Kidney Transplantation
Jefferson Health is one of nineteen transplant hospitals selected in the United States to participate in the initial pilot phase of the Collaborative Innovation and Improvement Network (COIIN), a three-year project intended to increase kidneys used for transplantation.
A Receptor Discovered for Progranulin
Researchers at Thomas Jefferson University’s Sidney Kimmel Cancer Center discovered a cell-surface receptor highly expressed by cancerous and brain cells that directly and tightly binds progranulin. Importantly, the researchers also showed that this binding activates a cellular program that makes cancer cells more aggressive.
14th Annual Jefferson Gala to Honor SAP CEO Bill McDermott & Renowned Surgeon Dr. Edmund Pribitkin
The 14th Annual Jefferson Gala will be celebrated on Tuesday, December 6 at the Philadelphia Marriott Downtown. This year’s Gala will honor Bill McDermott and Edmund Pribitkin, M.D., MBA, FACS.
Targeting Breast Cancer Metabolism to Fight the Disease
New research from Thomas Jefferson University shows that breast cancer cells rely on a different process for turning fuel into energy than normal cells. The results were recently published in the Journal of Biological Chemistry.
Philadelphia Eagles, Jefferson, and Rothman Institute Announce Partnership Renewal
The eight-year extension will run through the 2023 season
Psychedelic Drugs Trigger More Intense Mystical Experiences than Meditation or Prayer
Research could shed light on underlying biological mechanisms of mystical experiences and how these experiences influence well-being.